NCT02709005: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02709005 |
|---|---|
| Title | A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Assess the Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 14, 2016 |
| Completion date | Dec. 11, 2017 |
| Required reporting date | Dec. 11, 2018, midnight |
| Actual reporting date | Dec. 6, 2018 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |